whether to treat patients with subclinical hypothyroidism
There's controversy over whether to treat patients with subclinical hypothyroidism.
Subclinical hypothyroidism is defined as an elevated TSH with normal free T4.
Some of the controversy stems from terminology.
Table of Contents
- raising questions about FDA's drug approval and surveillance process
- Reps will be saying that amlodipine (Norvasc) reduces the risk of cardiovascular events
- BiDil will be the first drug approved specifically for African Americans
- Reps will be touting evidence that suggests carvedilol is better than metoprolol for diabetes patients
- whether to treat patients with subclinical hypothyroidism
- what really works for fibromyalgia
- DHEA for weight loss
- Light therapy is often as effective as antidepressants for seasonal affective disorder (SAD)
- Ritalin, Adderall, and other ADHD drugs to enhance test scores
- whether testosterone is appropriate for treating sexual dysfunction in women
- the risk of bone loss in women using Depo-Provera
- Tysabri (tie-SAB-ree), the latest treatment for multiple sclerosis (MS)
- Tarceva (erlotinib), a new ORAL treatment for non-small cell lung cancer (NSCLC)
- More women with EARLY breast cancer will be treated with an aromatase inhibitor
- flecainide (Tambocor) or propafenone (Rythmol) as needed for atrial fibrillation
- End of year is a good time to reflect on trustworthy drug information that is relevant to practice.